person
Christian S.
- Country
- Germany
- Department
- Klinik für Pneumologie, Thoraxonkologie, Schlaf- und Beatmungsmedizin
Research Overview
assignment
23
Clinical Trials ·
- Phase 3 Randomized Study of Nivolumab and Ipilimumab with Chemoradiotherapy in Locally Advanced Non-Small Cell Lung Cancer
- Comparison of Sotorasib Plus Combination Therapy Versus Pembrolizumab Plus Combination Therapy in PD-L1 Negative KRAS p.G12C Positive Advanced Non-Squamous NSCLC
- Phase 3 Multiregional Study of Ivonescimab with Chemotherapy vs. Pembrolizumab with Chemotherapy in Metastatic Squamous NSCLC
location_city
2
Research Sites
Data & Insights
medical_services
Primary Speciality
Main therapeutic area
handshake
Return Partnerships
Recurring site collaborations
281
Sites with multiple studies
Has run more than one trial at 281 of 515 partner sites.
Specializations
Non-Small Cell Lung Cancer (NSCLC) Expertise
This investigator specializes in treating various stages of non-small cell lung cancer, with particular focus on both resectable and metastatic disease. Their research encompasses early-stage through advanced NSCLC cases.
- Stage I-IIIB Treatment Approaches
- Advanced/Metastatic Disease Management
- Squamous and Non-squamous NSCLC
Targeted Therapy Focus
The investigator has extensive experience in molecular targeted therapies, particularly focusing on specific genetic mutations in lung cancer.
- EGFR Mutation Targeted Treatment
- KRAS G12C Mutation Therapy
- RET Fusion-Positive NSCLC
Immunotherapy Applications
Their work includes significant research in immunotherapy treatments and novel therapeutic combinations for lung cancer patients.
- PD-1/PD-L1 Inhibitor Therapy
- Combination Immunotherapy Approaches
- Small Cell Lung Cancer Immunotherapy
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.